144 related articles for article (PubMed ID: 10068577)
1. No evidence for an effect of the CCR5 delta32/+ and CCR2b 64I/+ mutations on human immunodeficiency virus (HIV)-1 disease progression among HIV-1-infected injecting drug users.
Schinkel J; Langendam MW; Coutinho RA; Krol A; Brouwer M; Schuitemaker H
J Infect Dis; 1999 Apr; 179(4):825-31. PubMed ID: 10068577
[TBL] [Abstract][Full Text] [Related]
2. Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection.
Mulherin SA; O'Brien TR; Ioannidis JP; Goedert JJ; Buchbinder SP; Coutinho RA; Jamieson BD; Meyer L; Michael NL; Pantaleo G; Rizzardi GP; Schuitemaker H; Sheppard HW; Theodorou ID; Vlahov D; Rosenberg PS;
AIDS; 2003 Feb; 17(3):377-87. PubMed ID: 12556692
[TBL] [Abstract][Full Text] [Related]
3. Chemokine receptor polymorphisms and human immunodeficiency virus disease progression.
Easterbrook PJ; Rostron T; Ives N; Troop M; Gazzard BG; Rowland-Jones SL
J Infect Dis; 1999 Oct; 180(4):1096-105. PubMed ID: 10479136
[TBL] [Abstract][Full Text] [Related]
4. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
[TBL] [Abstract][Full Text] [Related]
5. Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis.
Ioannidis JP; Contopoulos-Ioannidis DG; Rosenberg PS; Goedert JJ; De Rossi A; Espanol T; Frenkel L; Mayaux MJ; Newell ML; Pahwa SG; Rousseau C; Scarlatti G; Sei S; Sen L; O'Brien TR;
AIDS; 2003 Jul; 17(11):1631-8. PubMed ID: 12853745
[TBL] [Abstract][Full Text] [Related]
6. Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression.
de Roda Husman AM; van Rij RP; Blaak H; Broersen S; Schuitemaker H
J Infect Dis; 1999 Oct; 180(4):1106-15. PubMed ID: 10479137
[TBL] [Abstract][Full Text] [Related]
7. Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy.
Lathey JL; Tierney C; Chang SY; D'Aquila RT; Bettendorf DM; Alexander HC; Santini CD; Hughes AM; Barroga CF; Spector SA; Landes JE; Hammer SM; Katzenstein DA
J Infect Dis; 2001 Dec; 184(11):1402-11. PubMed ID: 11709782
[TBL] [Abstract][Full Text] [Related]
8. Host genetic background at CCR5 chemokine receptor and vitamin D receptor loci and human immunodeficiency virus (HIV) type 1 disease progression among HIV-seropositive injection drug users.
Barber Y; Rubio C; Fernández E; Rubio M; Fibla J
J Infect Dis; 2001 Nov; 184(10):1279-88. PubMed ID: 11679916
[TBL] [Abstract][Full Text] [Related]
9. Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection.
Singh KK; Barroga CF; Hughes MD; Chen J; Raskino C; McKinney RE; Spector SA
J Infect Dis; 2003 Nov; 188(10):1461-72. PubMed ID: 14624371
[TBL] [Abstract][Full Text] [Related]
10. Adverse effect of the CCR5 promoter -2459A allele on HIV-1 disease progression.
Knudsen TB; Kristiansen TB; Katzenstein TL; Eugen-Olsen J;
J Med Virol; 2001 Nov; 65(3):441-4. PubMed ID: 11596075
[TBL] [Abstract][Full Text] [Related]
11. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
[TBL] [Abstract][Full Text] [Related]
12. Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex.
van Rij RP; Portegies P; Hallaby T; Lange JM; Visser J; de Roda Husman AM; van 't Wout AB; Schuitemaker H
J Infect Dis; 1999 Sep; 180(3):854-7. PubMed ID: 10438379
[TBL] [Abstract][Full Text] [Related]
13. Role of CCR5, CCR2 and SDF-1 gene polymorphisms in a population of HIV-1 infected individuals.
Mazzucchelli R; Corvasce S; Violin M; Riva C; Bianchi R; Dehò L; Velleca R; Cibella J; Bada M; Moroni M; Galli M; Balotta C
J Biol Regul Homeost Agents; 2001; 15(3):265-71. PubMed ID: 11693435
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of CCR5-Δ32 against HIV infection by the heterosexual mode of transmission in a Polish population.
Zwolińska K; Knysz B; Rybka K; Pazgan-Simon M; Gąsiorowski J; Sobczyński M; Gładysz A; Piasecki E
AIDS Res Hum Retroviruses; 2013 Jan; 29(1):54-60. PubMed ID: 22957692
[TBL] [Abstract][Full Text] [Related]
15. Population survey of CCR5 delta32, CCR5 m303, CCR2b 64I, and SDF1 3'A allele frequencies in indigenous Chinese healthy individuals, and in HIV-1-infected and HIV-1-uninfected individuals in HIV-1 risk groups.
Wang FS; Hong WG; Cao Y; Liu MX; Jin L; Hu LP; Wang Z; Feng TJ; Hou J; Zhang B; Shi M; Xu DP; Lei ZY; Wang B; Liu ZD; Ye JJ; Peng L; Qiu Y; Winkler C
J Acquir Immune Defic Syndr; 2003 Feb; 32(2):124-30. PubMed ID: 12571520
[TBL] [Abstract][Full Text] [Related]
16. Genotypes and polymorphisms of mutant CCR5-delta 32, CCR2-64I and SDF1-3' a HIV-1 resistance alleles in indigenous Han Chinese.
Wang F; Jin L; Lei Z; Shi H; Hong W; Xu D; Jiang J; Wang Y; Zhang B; Liu M; Li Y
Chin Med J (Engl); 2001 Nov; 114(11):1162-6. PubMed ID: 11729511
[TBL] [Abstract][Full Text] [Related]
17. Genetic variations in CC chemokine receptors and hypertension.
Zhang M; Ardlie K; Wacholder S; Welch R; Chanock S; O'Brien TR
Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193
[TBL] [Abstract][Full Text] [Related]
18. Effect of chemokine receptor mutations on heterosexual human immunodeficiency virus transmission.
Lockett SF; Alonso A; Wyld R; Martin MP; Robertson JR; Gore SM; Leen CL; Brettle RP; Yirrell DL; Carrington M; Brown AJ
J Infect Dis; 1999 Sep; 180(3):614-21. PubMed ID: 10438347
[TBL] [Abstract][Full Text] [Related]
19. Distribution of CCR5 genotypes and HLA Class I B alleles in HIV-1 infected and uninfected injecting drug users from Rio de Janeiro, Brazil.
Teixeira SL; Bastos FI; Hacker MA; Morgado MG
Infect Genet Evol; 2009 Jul; 9(4):638-42. PubMed ID: 19460331
[TBL] [Abstract][Full Text] [Related]
20. Chemokine receptor CCR2b 64I polymorphism and its relation to CD4 T-cell counts and disease progression in a Danish cohort of HIV-infected individuals. Copenhagen AIDS cohort.
Eugen-Olsen J; Iversen AK; Benfield TL; Koppelhus U; Garred P
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):110-6. PubMed ID: 9637575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
